Léčba závažné tyreoidální orbitopatie hemoreoferézou, význam změn vybraných patogenetických činitelů

Haemorheopheresis in treatment of severe thyroid associated orbitopathy, the role of changes in selected pathogenetic indicators Introduction: Thyroid associated orbitopathy (TAO) is an autoimmune disease characterized by inflammatory swelling and cellular infiltration of orbital tissues. In severe...

Full description

Bibliographic Details
Main Author: Ceeová, Věra
Other Authors: Čáp, Jan
Format: Doctoral Thesis
Language:Czech
Published: 2015
Online Access:http://www.nusl.cz/ntk/nusl-350945
id ndltd-nusl.cz-oai-invenio.nusl.cz-350945
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-3509452021-03-29T05:12:50Z Léčba závažné tyreoidální orbitopatie hemoreoferézou, význam změn vybraných patogenetických činitelů Haemorheopheresis in treatment of severe thyroid associated orbitopathy, the role of changes in selected pathogenetic indicators Ceeová, Věra Čáp, Jan Zamrazil, Václav Fryšák, Zdeněk Haemorheopheresis in treatment of severe thyroid associated orbitopathy, the role of changes in selected pathogenetic indicators Introduction: Thyroid associated orbitopathy (TAO) is an autoimmune disease characterized by inflammatory swelling and cellular infiltration of orbital tissues. In severe cases causes disablement and disfigurement of patients. The treatment of choice has been for many years corticosteroid treatment. Its benefit was clearly demonstrated in spite of many important adverse events. The effect of other immunosuppressive treatment has not been clearly demonstrated. Objective: The aim of our study was to determine the effect of haemorheopheresis on the course of TAO in patients with very severe form of disease in a randomized study (10 patients treated with high doses of glucocorticosteroids and 10 patients on combination of glucocorticosteroids and haemorheopheresis). Secondary aim is to follow selected pathogenetically important immunological and biochemical parameters during haemorheopheretic treatment and to evaluate safety and tolerability of our method modification. Patients and methods: 20 patients with very severe form of disease, without improvement on standard glucocorticoid treatment were enrolled into the study. They were randomized into two groups. Ten patients were treated... 2015 info:eu-repo/semantics/doctoralThesis http://www.nusl.cz/ntk/nusl-350945 cze info:eu-repo/semantics/restrictedAccess
collection NDLTD
language Czech
format Doctoral Thesis
sources NDLTD
description Haemorheopheresis in treatment of severe thyroid associated orbitopathy, the role of changes in selected pathogenetic indicators Introduction: Thyroid associated orbitopathy (TAO) is an autoimmune disease characterized by inflammatory swelling and cellular infiltration of orbital tissues. In severe cases causes disablement and disfigurement of patients. The treatment of choice has been for many years corticosteroid treatment. Its benefit was clearly demonstrated in spite of many important adverse events. The effect of other immunosuppressive treatment has not been clearly demonstrated. Objective: The aim of our study was to determine the effect of haemorheopheresis on the course of TAO in patients with very severe form of disease in a randomized study (10 patients treated with high doses of glucocorticosteroids and 10 patients on combination of glucocorticosteroids and haemorheopheresis). Secondary aim is to follow selected pathogenetically important immunological and biochemical parameters during haemorheopheretic treatment and to evaluate safety and tolerability of our method modification. Patients and methods: 20 patients with very severe form of disease, without improvement on standard glucocorticoid treatment were enrolled into the study. They were randomized into two groups. Ten patients were treated...
author2 Čáp, Jan
author_facet Čáp, Jan
Ceeová, Věra
author Ceeová, Věra
spellingShingle Ceeová, Věra
Léčba závažné tyreoidální orbitopatie hemoreoferézou, význam změn vybraných patogenetických činitelů
author_sort Ceeová, Věra
title Léčba závažné tyreoidální orbitopatie hemoreoferézou, význam změn vybraných patogenetických činitelů
title_short Léčba závažné tyreoidální orbitopatie hemoreoferézou, význam změn vybraných patogenetických činitelů
title_full Léčba závažné tyreoidální orbitopatie hemoreoferézou, význam změn vybraných patogenetických činitelů
title_fullStr Léčba závažné tyreoidální orbitopatie hemoreoferézou, význam změn vybraných patogenetických činitelů
title_full_unstemmed Léčba závažné tyreoidální orbitopatie hemoreoferézou, význam změn vybraných patogenetických činitelů
title_sort léčba závažné tyreoidální orbitopatie hemoreoferézou, význam změn vybraných patogenetických činitelů
publishDate 2015
url http://www.nusl.cz/ntk/nusl-350945
work_keys_str_mv AT ceeovavera lecbazavaznetyreoidalniorbitopatiehemoreoferezouvyznamzmenvybranychpatogenetickychcinitelu
AT ceeovavera haemorheopheresisintreatmentofseverethyroidassociatedorbitopathytheroleofchangesinselectedpathogeneticindicators
_version_ 1719389912482971648